rtki cpd has been researched along with bumetanide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Asano, J; Dejima, K; Hama, T; Hisa, Y; Iwasaki, Y; Marunaka, Y; Miyazaki, H; Nakajima, K; Niisato, N; Yasuda, M | 1 |
2 other study(ies) available for rtki cpd and bumetanide
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quercetin stimulates Na+/K+/2Cl- cotransport via PTK-dependent mechanisms in human airway epithelium.
Topics: Brefeldin A; Bumetanide; Cell Line; Chlorides; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Humans; Ion Transport; Protein-Tyrosine Kinases; Quercetin; Quinazolines; Respiratory Mucosa; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Tyrphostins; Valinomycin | 2009 |